Please join us for a timely webinar, Cannabis Rescheduling: DOJ, Treasury, and DEA Updates, where our team will break down the rapidly unfolding federal developments in cannabis rescheduling. We will discuss the Department of Justice’s landmark Final Order immediately placing cannabis subject to a state medical marijuana license in Schedule III of the Controlled Substances Act, the practical implications for medical cannabis operators—including DEA registration, Section 280E tax relief, and the potential for retrospective relief from Treasury—as well as the DEA’s newly initiated hearing proceedings on the broader proposed rescheduling of all marijuana from Schedule I to Schedule III, set to commence June 29, 2026. We will also address the emerging legal challenges to the Final Order. 

Whether you are a state-licensed medical cannabis operator evaluating federal registration and compliance deadlines, a tax advisor helping clients assess the impact of Section 280E relief, an adult-use cannabis operator monitoring the broader rescheduling proceedings, or a stakeholder seeking to understand the evolving federal landscape, this webinar will equip you with the insights you need to stay ahead.